v3.19.1
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)
Jan. 31, 2019
Apr. 30, 2018
Current Assets:    
Cash $ 699,462 $ 1,059,798
Prepaid expenses and other current assets 8,484 224,067
Total Current Assets 707,946 1,283,865
Other assets:    
Intangibles 3,549,427 3,549,427
Investment in SG Austria 1,572,193 1,572,193
Other assets 7,372 7,372
Total other assets 5,128,992 5,128,992
Total Assets 5,836,938 6,412,857
Current Liabilities:    
Accounts payable 133,676 352,621
Accrued expenses 337,567 291,547
Total current liabilities 471,243 644,168
Total Liabilities 471,243 644,168
Commitments and Contingencies (Notes 6 and 8)
Stockholders' Equity    
Common stock: authorized 1,490,000,000 shares, $0.0001 par value, 1,126,904,505 and 1,013,260,644 shares issued and outstanding as of January 31, 2019 and April 30, 2018, respectively 112,690 101,326
Additional paid in capital 104,153,928 101,636,215
Accumulated deficit (98,892,427) (95,964,143)
Accumulated other comprehensive loss (8,496) (4,709)
Total stockholders' equity 5,365,695 5,768,689
Total Liabilities and Stockholders' Equity $ 5,836,938 $ 6,412,857

Source

v3.19.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
3 Months Ended 9 Months Ended
Jan. 31, 2019
Jan. 31, 2018
Jan. 31, 2019
Jan. 31, 2018
Revenues:        
Revenue $ 0 $ 0 $ 0 $ 0
Operating Expenses:        
Research and development costs 59,144 802,564 442,039 1,745,692
Compensation expense 371,571 636,999 1,199,252 1,793,946
Director fees 50,000 31,093 189,502 209,574
Legal and professional 57,224 107,149 242,318 434,688
General and administrative 138,408 452,855 855,173 1,349,473
Total operating expenses 676,347 2,030,660 2,928,284 5,533,373
Loss from operations (676,347) (2,030,660) (2,928,284) (5,533,373)
Net loss $ (676,347) $ (2,030,660) $ (2,928,284) $ (5,533,373)
Basic and diluted loss per share $ (0.00) $ (0.00) $ (0.00) $ (0.01)
Weighted average shares outstanding basic and diluted 1,126,904,505 975,848,246 1,084,053,016 958,198,483

Source

v3.19.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
9 Months Ended
Jan. 31, 2019
Jan. 31, 2018
Cash flows from operating activities:    
Net loss $ (2,928,284) $ (5,533,373)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock issued for services 140,884 201,576
Stock issued for compensation 245,520 488,290
Stock based compensation - options 282,673 766,382
Change in assets and liabilities:    
Decrease in prepaid expenses and other current assets 215,583 65,405
Decrease in accounts payable (218,945) (60,008)
Increase in accrued expenses 46,020 66,916
Increase in binding term sheet obligation 0 300,000
Net cash used in operating activities (2,216,549) (3,704,812)
Cash flows from investing activities:    
Net cash provided by (used in) investing activities 0 0
Cash flows from financing activities:    
Proceeds from sale of common stock, net of issuance costs 1,860,000 1,751,409
Net cash provided by financing activities 1,860,000 1,751,409
Effect of currency rate exchange on cash (3,787) (2,979)
Net decrease in cash (360,336) (1,956,382)
Cash at beginning of the period 1,059,798 3,464,229
Cash at end of the period $ 699,462 $ 1,507,847

Source